Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/23 18:05 | 9/6/23 | VAXX | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S.m | -169 | 1.74 | 0 | -97 | -1 | 16,657 | M | |||||||||||||||
5/2/23 10:46 | 4/26/23 | VAXX | Health | Drug | Pharmaceutical Preparations | Diamandis Peter | FL | D | M.d | 301 | 0.6326 | 0 | 476 | 31 | 2,020 | D | |||||||||||||||
1/25/23 17:58 | 1/23/23 | VAXX | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S | -1,678 | 3.35 | 0 | -501 | -3 | 16,754 | M | |||||||||||||||
12/5/22 17:31 | 12/1/22 | VAXX | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S.m | -1,030 | 2.96 | 0 | -349 | -2 | 17,255 | M | |||||||||||||||
9/8/22 16:55 | 9/6/22 | VAXX | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S | -90 | 2.40 | 0 | -37 | 0 | 17,603 | M | |||||||||||||||
8/29/22 16:45 | 1/13/22 | VAXX | Health | Drug | Pharmaceutical Preparations | Guirakhoo Farshad | TX | O | (Former) | M.dm | 33 | 0.5700 | 0 | 59 | 586 | 69 | D | ||||||||||||||
8/25/22 18:02 | 8/23/22 | VAXX | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S.m | -497 | 2.39 | 0 | -208 | -1 | 17,641 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |